Investors - Press Releases
|View printer-friendly version|
TRHC and ASCP Sign Letter of Intent to offer MedWise™ to Consultant Pharmacists
The principal value proposition of the collaboration is a working partnership between TRHC and ASCP to improve medication safety in patients who have a high burden of disease and complex medication regimens, while also developing consultant pharmacist workflow recommendations for its use.
According to ASCP’s Chief Executive
TRHC’s MedWise is a proprietary medication-safety technology that helps pharmacists manage and optimize regimens by presenting meaningful opportunities to mitigate risks. Benefits include simultaneous multi-drug analysis; identifying, resolving, and preventing adverse drug events; and reducing hospitalizations and emergency visits.
“For every dollar spent on prescription medication in this country, we spend more than another dollar trying to address medication-related problems,” said THRC Chairman and CEO
ASCP: Empowering Pharmacists. Transforming Aging.
ASCP is a membership association that represents pharmacists, health care professionals, and students serving the unique medication needs of older adults. ASCP is an international organization with members located in all 50 states,
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the
T: (215) 870-0829
T: (312) 451-2157
T: (856) 912-5714
Source: Tabula Rasa HealthCare, Inc.